Database Trends & Applications is excited to bring our community of data professionals together this May 13 - 15 in Boston for 3 days of practical advice, inspiring thought leadership, and in-depth ...
It was fully understood prior to the Data + AI Summit in San Francisco last week that Databricks Inc. was well-positioned in the marketplace but faced some critical strategic decisions in its future.
The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ivonescimab—have sparked a mix of hopes and concerns, leading to a 25% stock ...
We're excited to bring our community of data professionals together this May in Boston for three days of practical advice, inspiring thought leadership, and in-depth training. Join your peers to learn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback